Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

The study results reflect the effect of surgery with lymph node dissection alone in patients with high-grade invasive bladder cancer.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB). This is an ASCO Meeting ...

RFT Writers are a collective of independent journalists contributing original reporting to RFT. They report on a wide range of topics including music, news, gaming, cannabis, and the creator economy.

If awards were handed out for sheer lack of pretense, this would be a clean sweep. Feet are king here, their position is not up for debate. You want close attention paid to the tops? Settled, that’s ...